SUBSCRIBE

CATEGORIES

U.S. to send more than $100 million in COVID supplies to India

imageWorld17 minutes ago (Apr 28, 2021 11:35PM ET)

(C) Reuters. Mass cremation of coronavirus disease (COVID-19) victims at a crematorium in New Delhi

WASHINGTON (Reuters) -The United States is sending supplies worth more than $100 million to India to help it fight a surge of COVID-19 cases, the White House said in a statement on Wednesday.

The supplies, which will begin arriving on Thursday and continue into next week, include 1,000 oxygen cylinders, 15 million N95 masks and 1 million rapid diagnostic tests, the statement said.

The United States also has redirected its own order of AstraZeneca (NASDAQ:AZN) manufacturing supplies to India, which will allow it to make over 20 million doses of COVID-19 vaccine, according to the White House.

“Just as India sent assistance to the United States when our hospitals were strained early in the pandemic, the United States is determined to help India in its time of need,” the White House said in a fact sheet outlining the aid.

India’s death toll from the coronavirus pandemic surged past 200,000 on Wednesday, worsened by shortages of hospital beds and medical oxygen. The last 24 hours brought 360,960 new cases for the world’s largest single-day total, taking India’s tally of infections to nearly 18 million.

U.S. to send more than $100 million in COVID supplies to India

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.